News Release
News Release
- Home
- News Release
- Announcing the Start of Administration of Functional Peptide SR-0379 to Subjects in Phase III Clinical Trial
NEWS RELEASE
News Release
Announcing the Start of Administration of Functional Peptide SR-0379 to Subjects in Phase III Clinical Trial